GEMINI THERAPEUTICS INC (GMTX) Stock Income Statement
USA - NASDAQ:GMTX - US36870G1058 - Common Stock
1.35 USD
0 (0%)
1.32 USD
-0.03 (-2.22%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 42.19M | 68.70M | 810.00K | N/A | |||
| Research and Development | 24.46M | 48.62M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 17.73M | 20.09M | 820.00K | N/A | |||
| Operating Income | -42.19M | -68.70M | -810.00K | 0.00 | |||
| Interest Income/Expense | 421.00K | -2.14M | N/A | N/A | |||
| Other Income/Expense | 48.00K | -13.00K | N/A | N/A | |||
| Non Recurring Items | -1.70M | -1.01M | N/A | N/A | |||
| Income Before Taxes | -43.42M | -71.87M | -810.00K | N/A | |||
| Income Tax | N/A | N/A | 0.00 | N/A | |||
| Net Income | -43.42M | -71.87M | -810.00K | N/A | |||
| EBITDA | N/A | -68.47M | N/A | N/A | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.01 | -1.78 | -0.05 | N/A | |||
| Non GAAP EPS | N/A | -1.81 | N/A | N/A | |||
| Statistics | |||||||
All data in USD